DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Acute Respiratory Distress Syndrome - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Respiratory Distress Syndrome ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include acute respiratory distress syndrome. The selected reports were submitted to the FDA during the sample period of about a year.

Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from France on 2012-08-10

Patient:

Reactions: Interstitial Lung Disease, Sepsis, Acute Respiratory Distress Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 50 ?g, qw
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-05-01

Placebo
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded Post Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded PRE Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded Post Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded Post Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-06-01

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Placebo
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-06-01

Peginterferon Alfa-2B
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded PRE Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-26
    End date: 2011-06-01

Blinded PRE Trial Therapy
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Peginterferon Alfa-2B
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2011-06-01

Other drugs received by patient: Prilosec; Dihydroergotamine Mesylate; Cyanocobalamin; Neorecormon; Propranolol Hydrochloride



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-24

Patient:

Reactions: Acute Respiratory Distress Syndrome

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk, qw
    Indication: Hepatitis C
    Start date: 2012-01-01

PEG-Intron
    Dosage: unk, qw
    Start date: 2012-02-01

Other drugs received by patient: Rebetol; Procrit



Possible PEG-Intron side effects in 65 year old male

Reported by a physician from Japan on 2012-06-04

Patient: 65 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: White Blood Cell Count Decreased, Drug Eruption, Pruritus, Nausea, Headache, Rash, Haemoglobin Decreased, Malaise, Fatigue, Acute Respiratory Distress Syndrome

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-02-16

Telavic (Antivirals Nos)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-16
    End date: 2012-04-26

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-04-04

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-16
    End date: 2012-03-15

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05

Other drugs received by patient: Lendormin; Amlodipine; Prednisolone; Glimerpride; Lansoprazole; Rikkunshi-TO; Olopatadine HCL; Primperan TAB; Citicoline; Nizoral Cream



Possible PEG-Intron side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-05-31

Patient: 59 year old female

Reactions: Jaundice, White Blood Cell Count Decreased, Dyspnoea, Haematuria, Anaemia, Transfusion Reaction, Oesophageal Varices Haemorrhage, Activated Partial Thromboplastin Time Shortened, Acute Respiratory Distress Syndrome, Platelet Count Decreased, Oedema, Bradycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-03-28
    End date: 2012-05-16

Ribavirin
    Dosage: 200 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-28
    End date: 2012-05-16

Victrelis
    Dosage: 800 mg;tid
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-16

Other drugs received by patient: Spironolactone; Levothyroxine Sodium; Propranolol



Possible PEG-Intron side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from Colombia on 2012-05-30

Patient: 59 year old female

Reactions: Anaemia, Haematuria, Acute Respiratory Distress Syndrome, Bradycardia, Oesophageal Varices Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-09
    End date: 2012-05-16

Ribavirin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-02
    End date: 2012-05-16

Victrelis
    Dosage: 800 mg;tid;
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-02
    End date: 2012-05-16



Possible PEG-Intron side effects in 65 year old male

Reported by a physician from Japan on 2012-05-30

Patient: 65 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: White Blood Cell Count Decreased, Drug Eruption, Pruritus, Nausea, Rash, Headache, Haemoglobin Decreased, Fatigue, Malaise, Acute Respiratory Distress Syndrome

Drug(s) suspected as cause:
Telavic (Antivirals Nos)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-16
    End date: 2012-04-26

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-04-04

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05

Rebetol
    Dosage: 800 mg;qd;po 600 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-16
    End date: 2012-03-15

PEG-Intron
    Dosage: 1.5 mcg/kg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-02-16

Other drugs received by patient: Lendormin; Nizoral Cream; Olopatadine HCL; Primperan TAB; Glimepiride; Prednisolone; Amlodipine; Citicoline; Lansoprazole; Rikkunshi-TO



Possible PEG-Intron side effects in 5 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09

Patient: 5 year old male, weighing 32.5 kg (71.5 pounds)

Reactions: Renal Tubular Disorder, Dyskinesia, Disseminated Intravascular Coagulation, Petechiae, Hepatic Failure, Mental Status Changes, Coma, Headache, Pyrexia, Lactic Acidosis, Urine Output Increased, Generalised Oedema, Malaise, Acute Respiratory Distress Syndrome, Pulmonary Oedema, Electrolyte Imbalance, Vomiting, International Normalised Ratio Increased, Respiratory Distress, Tremor, Nephrogenic Diabetes Insipidus, Convulsion, Renal Failure, Product Packaging Issue, Mitochondrial Toxicity, Depressed Level of Consciousness, Rash Maculo-Papular, Multi-Organ Disorder, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 445 mg;once;rtl
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

Acetaminophen
    Dosage: 400 mg;once ; 400 mg;once
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

Acetaminophen
    Dosage: 400 mg;once ; 400 mg;once
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-07

PEG-Intron
    Dosage: 64 mcg;sc
    Indication: Hepatitis C
    Start date: 2010-01-07
    End date: 2010-01-07

Rebetol
    Dosage: 240 mg;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-01-07
    End date: 2010-01-07



Possible PEG-Intron side effects in 40 year old male

Reported by a physician from Taiwan, Province of China on 2012-02-07

Patient: 40 year old male

Reactions: Incorrect Route of Drug Administration, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 mcg;qw;im ; 100 mcg;qw;im ; 100 mcg;qw;im
    Indication: Hepatitis C
    Start date: 2011-12-21
    End date: 2011-12-21

PEG-Intron
    Dosage: 100 mcg;qw;im ; 100 mcg;qw;im ; 100 mcg;qw;im
    Indication: Hepatitis C
    Start date: 2011-12-08
    End date: 2011-12-08

PEG-Intron
    Dosage: 100 mcg;qw;im ; 100 mcg;qw;im ; 100 mcg;qw;im
    Indication: Hepatitis C
    Start date: 2011-12-15
    End date: 2011-12-15

Rebetol
    Dosage: 200 mg;bid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-08

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014